Content
09/17/2024
Seattle, WA USA
Arzeda
completed $38 million Series C Round funding. Investors include
Bunge Ventures, Conti Ventures, Fall Line Capital, Lewis & Clark Ventures, Sofinnova Partners, Sucden Ventures.
About
Arzeda, The Protein Design Company™, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications.
Startup
Sector:
Biotech
Materials
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
